Get started
ELI LILLY AND COMPANYELI LILLY AND COMPANYELI LILLY AND COMPANY

ELI LILLY AND COMPANY

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

LLY chart


Full chart

Key facts today

Eli Lilly missed sales goals for Mounjaro and Zepbound, raising concerns in the obesity drug market. The company aims to boost Zepbound and will share late-stage results for orforglipron next year.
Eli Lilly's weight-loss drug Zepbound (Mounjaro) outperforms Novo Nordisk's Wegovy, highlighting competition in the GLP-1 market. The company is also working on oral versions of these treatments.
Redburn Atlantic raised its price target for Eli Lilly to $700 from $640, keeping a neutral rating. Analysts' targets for Eli Lilly range from $580 to $1,250, with an average rating of outperform.
Analyze the impactAnalyze the impact

LLY upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪777.42 B‬USD
Dividend yield (indicated)
0.63%
Price to earnings Ratio (TTM)
90.867
Basic EPS (TTM)
9.167USD
Net income (FY)
‪5.24 B‬USD
Revenue (FY)
‪34.12 B‬USD
Shares float
‪850.72 M‬
Beta (1Y)
0.85

Employees


Employees (FY)
‪43 K‬
Change (1Y)
‪+4 K‬ +10.26%
Revenue / Employee (1Y)
‪793.58 K‬USD
Net income / Employee (1Y)
‪121.87 K‬USD

About Eli Lilly and Company


Sector
Health Technology
CEO
David A. Ricks
Headquarters
Indianapolis
Website
lilly.com
Founded
1876
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas



See all ideas 

LLY news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

LLY highest yielding bonds


US532457AM0
ELI LILLY 2025
Yield to maturity
6.07%
Maturity date
Jun 1, 2025
LLY4099975
Eli Lilly and Company 4.65% 15-JUN-2044
Yield to maturity
5.39%
Maturity date
Jun 15, 2044
LLY5871804
Eli Lilly and Company 5.2% 14-AUG-2064
Yield to maturity
5.32%
Maturity date
Aug 14, 2064
LLY5750032
Eli Lilly and Company 5.1% 09-FEB-2064
Yield to maturity
5.30%
Maturity date
Feb 9, 2064
US532457BS6
ELI LILLY 19/39
Yield to maturity
5.28%
Maturity date
Mar 15, 2039
LLY.GG
Eli Lilly and Company 6.77% 01-JAN-2036
Yield to maturity
5.24%
Maturity date
Jan 1, 2036
LLY5547404
Eli Lilly and Company 4.875% 27-FEB-2053
Yield to maturity
5.23%
Maturity date
Feb 27, 2053
LLY5547405
Eli Lilly and Company 4.95% 27-FEB-2063
Yield to maturity
5.22%
Maturity date
Feb 27, 2063
LLY5750031
Eli Lilly and Company 5.0% 09-FEB-2054
Yield to maturity
5.22%
Maturity date
Feb 9, 2054
LLY5871803
Eli Lilly and Company 5.05% 14-AUG-2054
Yield to maturity
5.21%
Maturity date
Aug 14, 2054
US532457BT4
ELI LILLY 19/49
Yield to maturity
5.14%
Maturity date
Mar 15, 2049

Explore more bonds 

Sparks


Curated watchlists where LLY is featured.

See all sparks 

Frequently Asked Questions


The current price of LLY is 830.660 USD — it has decreased by −8.00% in the past 24 hours. Watch ELI LILLY AND COMPANY stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BCS exchange ELI LILLY AND COMPANY stocks are traded under the ticker LLY.
LLY stock has fallen by −9.50% compared to the previous week, the month change is a −9.50% fall, over the last year ELI LILLY AND COMPANY has showed a −8.20% decrease.
We've gathered analysts' opinions on ELI LILLY AND COMPANY future price: according to them, LLY price has a max estimate of 1,250.00 USD and a min estimate of 700.00 USD. Watch LLY chart and read a more detailed ELI LILLY AND COMPANY stock forecast: see what analysts think of ELI LILLY AND COMPANY and suggest that you do with its stocks.
LLY reached its all-time high on Sep 16, 2024 with the price of 925.000 USD, and its all-time low was 775.930 USD and was reached on Oct 30, 2024. View more price dynamics on LLY chart.
See other stocks reaching their highest and lowest prices.
LLY stock is 1.81% volatile and has beta coefficient of 0.85. Track ELI LILLY AND COMPANY stock price on the chart and check out the list of the most volatile stocks — is ELI LILLY AND COMPANY there?
Today ELI LILLY AND COMPANY has the market capitalization of ‪777.42 B‬, it has decreased by −4.99% over the last week.
Yes, you can track ELI LILLY AND COMPANY financials in yearly and quarterly reports right on TradingView.
ELI LILLY AND COMPANY is going to release the next earnings report on Jan 30, 2025. Keep track of upcoming events with our Earnings Calendar.
LLY earnings for the last quarter are 1.18 USD per share, whereas the estimation was 1.42 USD resulting in a −16.97% surprise. The estimated earnings for the next quarter are 5.46 USD per share. See more details about ELI LILLY AND COMPANY earnings.
ELI LILLY AND COMPANY revenue for the last quarter amounts to ‪11.44 B‬ USD, despite the estimated figure of ‪12.10 B‬ USD. In the next quarter, revenue is expected to reach ‪14.02 B‬ USD.
LLY net income for the last quarter is ‪970.30 M‬ USD, while the quarter before that showed ‪2.97 B‬ USD of net income which accounts for −67.30% change. Track more ELI LILLY AND COMPANY financial stats to get the full picture.
Yes, LLY dividends are paid quarterly. The last dividend per share was 1.30 USD. As of today, Dividend Yield (TTM)% is 0.61%. Tracking ELI LILLY AND COMPANY dividends might help you take more informed decisions.
ELI LILLY AND COMPANY dividend yield was 0.78% in 2023, and payout ratio reached 77.91%. The year before the numbers were 1.07% and 56.79% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 5, 2024, the company has ‪43.00 K‬ employees. See our rating of the largest employees — is ELI LILLY AND COMPANY on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ELI LILLY AND COMPANY EBITDA is ‪16.11 B‬ USD, and current EBITDA margin is 34.73%. See more stats in ELI LILLY AND COMPANY financial statements.
Like other stocks, LLY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ELI LILLY AND COMPANY stock right from TradingView charts — choose your broker and connect to your account.